<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18093/0869-0189-2026-36-3-497-505</article-id><article-id custom-type="elpub" pub-id-type="custom">pulmo-4901</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАМЕТКИ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRACTICAL NOTES</subject></subj-group></article-categories><title-group><article-title>Лимфангиолейомиоматоз, ассоциированный с туберозным склерозом: клиническое наблюдение</article-title><trans-title-group xml:lang="en"><trans-title>Lymphangioleiomyomatosis associated with tuberous sclerosis: a clinical case report</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9451-9318</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Канаева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kanaeva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канаева Татьяна Владимировна – к. м. н., ассистент кафедры госпитальной терапии </p><p>410012, Саратов, ул. Большая Казачья, 112</p></bio><bio xml:lang="en"><p>Tatyana V. Kanaeva, Assistant Professor, Department of Hospital Therapy</p><p>ul. Bol’shaya Kazach’ya 112, Saratov, 410012</p></bio><email xlink:type="simple">tatyanakanaeva7795@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7464-826X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кароли</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Karoli</surname><given-names>N A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кароли Нина Анатольевна – д. м. н., профессор кафедры госпитальной терапии лечебного факультета</p><p>410012, Саратов, ул. Большая Казачья, 112</p></bio><bio xml:lang="en"><p>Nina A. Karoli, Doctor of Medicine, Professor, Department of Hospital Therapy, Faculty of Medicine</p><p>ul. Bol’shaya Kazach’ya 112, Saratov, 410012</p></bio><email xlink:type="simple">nina.karoli.73@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Саратовский государственный медицинский университет имени В.И.Разумовского» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Saratov State Medical University named after V.I.Razumovsky”, Healthcare Ministry of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Саратовский государственный медицинский университет имени В.И. Разумовского» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Saratov State Medical University named after V.I.Razumovsky”, Healthcare Ministry of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>22</day><month>06</month><year>2026</year></pub-date><volume>36</volume><issue>3</issue><fpage>497</fpage><lpage>505</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Канаева Т.В., Кароли Н.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Канаева Т.В., Кароли Н.А.</copyright-holder><copyright-holder xml:lang="en">Kanaeva T.V., Karoli N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/4901">https://journal.pulmonology.ru/pulm/article/view/4901</self-uri><abstract><p>Лимфангиолейомиоматоз (ЛАМ) – это редкое, системное и прогрессирующее опухолевое заболевание, характеризуемое аномальной пролиферацией веретенообразных гладкомышечных клеток. Эти клетки проникают в легкие, почки и лимфатическую систему, что приводит к развитию диффузных тонкостенных кист легких, почечных ангиомиолипом и различных лимфатических аномалий. Выделяются 2 основных варианта ЛАМ – спорадический (сЛАМ) и ассоциированный с туберозным склерозом (ТС-ЛАМ). Заболевание имеет выраженную гендерную предрасположенность и поражает преимущественно женщин репродуктивного возраста; ЛАМ у мужчин встречается крайне редко.</p><p>Целью работы являлось описание случая длительного наблюдения за пациенткой с ТС-ЛАМ на фоне терапии эверолимусом.</p><sec><title>Результаты</title><p>Результаты. В представленном клиническом наблюдении продемонстрировано относительно доброкачественное течение заболевания у пациентки с диагностированным в детском возрасте ТС, поражением кожи, нарастанием азотемии на фоне разрыва ангиомиолипомы почки и выявлением ЛАМ в зрелом возрасте. На фоне своевременного назначения ингибиторов mTOR наблюдалось восстановление функции почек, не было существенного нарастания нарушения функции внешнего дыхания.</p></sec><sec><title>Заключение</title><p>Заключение. Мультидисциплинарный подход к обследованию и лечению больных ТС является ключевым фактором в своевременной верификации диагноза и выборе терапевтической тактики, способствует снижению риска прогрессирования органной дисфункции.</p></sec></abstract><trans-abstract xml:lang="en"><p>Lymphangioleiomyomatosis (ЛАМ) is a rare, systemic and progressive tumor disease characterized by abnormal proliferation of fusiform smooth muscle cells. These cells penetrate into the lungs, kidneys, and lymphatic system, which leads to the development of diffuse thin-walled lung cysts, renal angiomyelitis, and various lymphatic abnormalities. There are 2 main variants of ЛАМ: sporadic ЛАМ (sЛАМ) and ЛАМ associated with tuberous sclerosis (TS). The disease has a pronounced gender predisposition and affects mainly women of reproductive age. ЛАМ in men is extremely rare.</p><p>The aim of this study was to demonstrate clinical case of long-term follow-up of a patient with ЛАМ associated with TS with the background of everolimus therapy.</p><sec><title>Results</title><p>Results. The presented clinical observation demonstrates a relatively benign course of the disease in a patient with TS diagnosed in childhood, with skin lesions, an increase in azotemia against the background of rupture of renal angiomyolipoma, and ЛАМ detected in adulthood. Timely administration of mTOR inhibitors was associated with recovering renal function and no significant increase in pulmonary function impairment.</p></sec><sec><title>Conclusion</title><p>Conclusion. A multidisciplinary approach to the examination and treatment of patients with TS is a key factor in timely diagnosis verification, timely therapeutic tactics, and reducing the risk of progressing organ dysfunction.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>туберозный склероз</kwd><kwd>лимфангиолейомиоматоз</kwd><kwd>ингибиторы mTOR</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberous sclerosis</kwd><kwd>lymphangioleiomyomatosis</kwd><kwd>mTOR inhibitors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Макарова М.А., Белевский А.С. Лимфангиолейомиоматоз спорадический и ассоциированный с туберозным склерозом: взгляд пульмонолога. Пульмонология. 2025; 35 (3): 403–411. DOI: 10.18093/0869-0189-2025-35-3-403-411.</mixed-citation><mixed-citation xml:lang="en">Makarova M.A., Belevskiy A.S. [Lymphangioleiomy-omatosis sporadic and associated with tuberous sclerosis: a pulmonologist’s view]. Pul’monologiya. 2025; 35 (3): 403–411. DOI: 10.18093/0869-0189-2025-35-3-403-411 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson S.R., Cordier J.F., Lazor R. et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. 2010; 35 (1): 14–26. DOI: 10.1183/09031936.00076209.</mixed-citation><mixed-citation xml:lang="en">Johnson S.R., Cordier J.F., Lazor R. et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. 2010; 35 (1): 14–26. DOI: 10.1183/09031936.00076209.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta N., Finlay G.A., Kotloff R.M. et al. Lymphan-gioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society/Japanese Respiratory Society clinical practice guideline. Am. J. Respir. Crit. Care Med. 2017; 196 (10): 1337–1348. DOI: 10.1164/rccm.201709-1965ST.</mixed-citation><mixed-citation xml:lang="en">Gupta N., Finlay G.A., Kotloff R.M. et al. Lymphan-gioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society/Japanese Respiratory Society clinical practice guideline. Am. J. Respir. Crit. Care Med. 2017; 196 (10): 1337–1348. DOI: 10.1164/rccm.201709-1965ST.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rodenko P.N., Elefteratos J., Rodenko E.L. et al. Sporadic lymphangioleiomyoma-tosis in a 35-year-old female patient: a rare cause of spontaneous pneumothorax. Cureus. 2025; 17 (7): e87346. DOI: 10.7759/cureus.87346.</mixed-citation><mixed-citation xml:lang="en">Rodenko P.N., Elefteratos J., Rodenko E.L. et al. Sporadic lymphangioleiomyoma-tosis in a 35-year-old female patient: a rare cause of spontaneous pneumothorax. Cureus. 2025; 17 (7): e87346. DOI: 10.7759/cureus.87346.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">McCarthy C., Gupta N., Johnson S.R. et al. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir. Med. 2021; 9 (11): 1313–1327. DOI: 10.1016/S2213-2600(21)00228-9.</mixed-citation><mixed-citation xml:lang="en">McCarthy C., Gupta N., Johnson S.R. et al. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir. Med. 2021; 9 (11): 1313–1327. DOI: 10.1016/S2213-2600(21)00228-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shah J.M., Patel J.T., Shah H. et al. The epidemiology and clinical features of lymphangioleiomyomatosis (LAM): a descriptive study of 33 case reports. Cureus. 2023; 15 (8): e43513. DOI: 10.7759/cureus.43513.</mixed-citation><mixed-citation xml:lang="en">Shah J.M., Patel J.T., Shah H. et al. The epidemiology and clinical features of lymphangioleiomyomatosis (LAM): a descriptive study of 33 case reports. Cureus. 2023; 15 (8): e43513. DOI: 10.7759/cureus.43513.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Дорофеева М.Ю., Белоусова Е.Д., Пивоварова А.М. Рекомендации по диагностике и лечению туберозного склероза. Журнал неврологии и психиатрии имени С.С.Корсакова. 2014; 114 (3): 58–74. Доступно на: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2014/3/031997-72982014310?ysclid=mowjli297a805910783</mixed-citation><mixed-citation xml:lang="en">Dorofeeva M.Iu., Belousova E.D., Pivovarova A.M. [Recommendations for diagnosis and treatment of tuberous sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S.Korsakova. 2014; 114 (3): 58–74. Available at: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2014/3/031997-72982014310?ysclid=mowjli297a805910783 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H., Hu Z., Wang S. et al. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: a review. Medicine (Baltimore). 2022; 101 (52): e32492. DOI: 10.1097/MD.0000000000032492.</mixed-citation><mixed-citation xml:lang="en">Zhang H., Hu Z., Wang S. et al. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: a review. Medicine (Baltimore). 2022; 101 (52): e32492. DOI: 10.1097/MD.0000000000032492.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ryu J.H., Sykes A.M., Lee A.S., Burger C.D. Cystic lung disease is not uncommon in men with tuberous sclerosis complex. Respir. Med. 2012; 106 (11): 1586–1590. DOI: 10.1016/j.rmed.2012.07.007.</mixed-citation><mixed-citation xml:lang="en">Ryu J.H., Sykes A.M., Lee A.S., Burger C.D. Cystic lung disease is not uncommon in men with tuberous sclerosis complex. Respir. Med. 2012; 106 (11): 1586–1590. DOI: 10.1016/j.rmed.2012.07.007.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Черняк А.В., Макарова М.А., Авдеев С.Н. Функция внешнего дыхания у больных лимфангиолейомиоматозом. Бюллетень физиологии и патологии дыхания. 2021; (79): 21–31. DOI: 10.36604/1998-5029-2021-79-21-31.</mixed-citation><mixed-citation xml:lang="en">Chernyak A.V., Makarova M.A., Avdeev S.N. [Lung function in patients with lymphangioleiomyomatosis]. Byulleten' fiziologii i patologii dykhaniya. 2021; (79): 21–31. DOI: 10.36604/1998-5029-2021-79-21-31 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Northrup H., Aronow M.E., Bebin E.M. et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr. Neurol. 2021; 123: 50–66. DOI: 10.1016/j.pediatrneurol.2021.07.011.</mixed-citation><mixed-citation xml:lang="en">Northrup H., Aronow M.E., Bebin E.M. et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr. Neurol. 2021; 123: 50–66. DOI: 10.1016/j.pediatrneurol.2021.07.011.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dibble C.C., Elis W., Menon S. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex up-stream of mTORC1. Mol. Cell. 2012; 47 (4): 535–546. DOI: 10.1016/j.molcel.2012.06.009.</mixed-citation><mixed-citation xml:lang="en">Dibble C.C., Elis W., Menon S. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex up-stream of mTORC1. Mol. Cell. 2012; 47 (4): 535–546. DOI: 10.1016/j.molcel.2012.06.009.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 2006; 355 (13): 1345–1356. DOI: 10.1056/NEJMra055323.</mixed-citation><mixed-citation xml:lang="en">Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 2006; 355 (13): 1345–1356. DOI: 10.1056/NEJMra055323.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wakida K., Watanabe Y., Kumasaka T. et al. Lymphangioleiomyomatosis in a male. Ann. Thorac. Surg. 2015; 100 (3): 1105–1107. DOI: 10.1016/j.athoracsur.2014.11.069.</mixed-citation><mixed-citation xml:lang="en">Wakida K., Watanabe Y., Kumasaka T. et al. Lymphangioleiomyomatosis in a male. Ann. Thorac. Surg. 2015; 100 (3): 1105–1107. DOI: 10.1016/j.athoracsur.2014.11.069.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta N., Henske E.P. Pulmonary manifestations in tuberous sclerosis complex. Am. J. Med. Genet. C Semin. Med. Genet. 2018; 178 (3): 326–337. DOI: 10.1002/ajmg.c.31638.</mixed-citation><mixed-citation xml:lang="en">Gupta N., Henske E.P. Pulmonary manifestations in tuberous sclerosis complex. Am. J. Med. Genet. C Semin. Med. Genet. 2018; 178 (3): 326–337. DOI: 10.1002/ajmg.c.31638.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Obraztsova K., Basil M.C., Rue R. et al. mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline. Nat. Commun. 2020; 11 (1): 5640. DOI: 10.1038/s41467-020-18979-4.</mixed-citation><mixed-citation xml:lang="en">Obraztsova K., Basil M.C., Rue R. et al. mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline. Nat. Commun. 2020; 11 (1): 5640. DOI: 10.1038/s41467-020-18979-4.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kundu N., Holz M.K. Lymphangioleiomyomatosis: a metastatic lung disease. Am. J. Physiol. Cell Physiol. 2023; 324 (2): C320–C326. DOI: 10.1152/ajpcell.00202.2022.</mixed-citation><mixed-citation xml:lang="en">Kundu N., Holz M.K. Lymphangioleiomyomatosis: a metastatic lung disease. Am. J. Physiol. Cell Physiol. 2023; 324 (2): C320–C326. DOI: 10.1152/ajpcell.00202.2022.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chang W.Y., Cane J.L., Blakey J.D. et al. Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. Respir. Res. 2012; 13 (1): 34. DOI: 10.1186/1465-9921-13-34.</mixed-citation><mixed-citation xml:lang="en">Chang W.Y., Cane J.L., Blakey J.D. et al. Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. Respir. Res. 2012; 13 (1): 34. DOI: 10.1186/1465-9921-13-34.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Taveira-DaSilva A.M, Jones A.M, Julien-Williams P. et al. Long-term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis. Chest. 2018; 153 (1): 124–132. DOI: 10.1016/j.chest.2017.05.012.</mixed-citation><mixed-citation xml:lang="en">Taveira-DaSilva A.M, Jones A.M, Julien-Williams P. et al. Long-term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis. Chest. 2018; 153 (1): 124–132. DOI: 10.1016/j.chest.2017.05.012.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">O’Mahony A.M., Lynn E., Murphy D.J. et al. Lymphangioleiomyomatosis: a clinical review. Breathe (Sheff.). 2020; 16 (2): 200007. DOI: 10.1183/20734735.0007-2020.</mixed-citation><mixed-citation xml:lang="en">O’Mahony A.M., Lynn E., Murphy D.J. et al. Lymphangioleiomyomatosis: a clinical review. Breathe (Sheff.). 2020; 16 (2): 200007. DOI: 10.1183/20734735.0007-2020.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
